Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1997 Sep 15;326(Pt 3):829–836. doi: 10.1042/bj3260829

Binding of perlecan to transthyretin in vitro.

S Smeland 1, S O Kolset 1, M Lyon 1, K R Norum 1, R Blomhoff 1
PMCID: PMC1218739  PMID: 9307034

Abstract

Transthyretin is one of two specific proteins involved in the transport of thyroid hormones in plasma; it possesses two binding sites for serum retinol-binding protein. In the present study we demonstrate that transthyretin also interacts in vitro with [35S]sulphate-labelled material from the medium of HepG2 cells. By using the same strategy as for purifying serum retinol-binding protein, [35S]sulphate-labelled medium was specifically eluted from a transthyretin-affinity column. Ion-exchange chromatography showed that the material was highly polyanionic, and its size and alkali susceptibility suggested that it was a proteoglycan. Structural analyses with chondroitinase ABC lyase and nitrous acid revealed that approx. 20% was chondroitin sulphate and 80% heparan sulphate. Immunoprecipitation showed that the [35S]sulphate-labelled material contained perlecan. Further analysis by binding studies revealed specific and saturable binding of 125I-transthyretin to perlecan-enriched Matrigel. Because inhibition of sulphation by treating HepG2 cells with sodium chlorate increased the affinity of the perlecan for transthyretin, and [3H]heparin was not retained by the transthyretin affinity column, the binding is probably mediated by the core protein and is not a protein-glycosaminoglycan interaction. Because perlecan is released from transthyretin in water, the binding might be due to hydrophobic interactions.

Full Text

The Full Text of this article is available as a PDF (453.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blake C. C., Geisow M. J., Oatley S. J., Rérat B., Rérat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol. 1978 May 25;121(3):339–356. doi: 10.1016/0022-2836(78)90368-6. [DOI] [PubMed] [Google Scholar]
  2. Blomhoff R., Green M. H., Berg T., Norum K. R. Transport and storage of vitamin A. Science. 1990 Oct 19;250(4979):399–404. doi: 10.1126/science.2218545. [DOI] [PubMed] [Google Scholar]
  3. Båvik C. O., Lévy F., Hellman U., Wernstedt C., Eriksson U. The retinal pigment epithelial membrane receptor for plasma retinol-binding protein. Isolation and cDNA cloning of the 63-kDa protein. J Biol Chem. 1993 Sep 25;268(27):20540–20546. [PubMed] [Google Scholar]
  4. Cavallaro T., Martone R. L., Dwork A. J., Schon E. A., Herbert J. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci. 1990 Mar 1;31(3):497–501. [PubMed] [Google Scholar]
  5. Couchman J. R., Kapoor R., Sthanam M., Wu R. R. Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix. J Biol Chem. 1996 Apr 19;271(16):9595–9602. doi: 10.1074/jbc.271.16.9595. [DOI] [PubMed] [Google Scholar]
  6. David G., van der Schueren B., Marynen P., Cassiman J. J., van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol. 1992 Aug;118(4):961–969. doi: 10.1083/jcb.118.4.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Episkopou V., Maeda S., Nishiguchi S., Shimada K., Gaitanaris G. A., Gottesman M. E., Robertson E. J. Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2375–2379. doi: 10.1073/pnas.90.6.2375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ferguson R. N., Edelhoch H., Saroff H. A., Robbins J., Cahnmann H. J. Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid. Biochemistry. 1975 Jan 28;14(2):282–289. doi: 10.1021/bi00673a014. [DOI] [PubMed] [Google Scholar]
  9. Friederich E., Fritz H. J., Huttner W. B. Inhibition of tyrosine sulfation in the trans-Golgi retards the transport of a constitutively secreted protein to the cell surface. J Cell Biol. 1988 Nov;107(5):1655–1667. doi: 10.1083/jcb.107.5.1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ingenbleek Y., Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr. 1994;14:495–533. doi: 10.1146/annurev.nu.14.070194.002431. [DOI] [PubMed] [Google Scholar]
  11. Iozzo R. V., Cohen I. R., Grässel S., Murdoch A. D. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J. 1994 Sep 15;302(Pt 3):625–639. doi: 10.1042/bj3020625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Iozzo R. V., Hassell J. R. Identification of the precursor protein for the heparan sulfate proteoglycan of human colon carcinoma cells and its post-translational modifications. Arch Biochem Biophys. 1989 Feb 15;269(1):239–249. doi: 10.1016/0003-9861(89)90105-7. [DOI] [PubMed] [Google Scholar]
  13. Kisilevsky R., Lyon A. W., Young I. D. A critical analysis of postulated pathogenetic mechanisms in amyloidogenesis. Crit Rev Clin Lab Sci. 1992;29(1):59–82. doi: 10.3109/10408369209105246. [DOI] [PubMed] [Google Scholar]
  14. Kolset S. O., Kjellén L., Seljelid R., Lindahl U. Changes in glycosaminoglycan biosynthesis during differentiation in vitro of human monocytes. Biochem J. 1983 Mar 15;210(3):661–667. doi: 10.1042/bj2100661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kolset S. O., Mann D. M., Uhlin-Hansen L., Winberg J. O., Ruoslahti E. Serglycin-binding proteins in activated macrophages and platelets. J Leukoc Biol. 1996 Apr;59(4):545–554. doi: 10.1002/jlb.59.4.545. [DOI] [PubMed] [Google Scholar]
  16. Lories V., Cassiman J. J., Van den Berghe H., David G. Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J Biol Chem. 1992 Jan 15;267(2):1116–1122. [PubMed] [Google Scholar]
  17. Lyon M., Deakin J. A., Gallagher J. T. Liver heparan sulfate structure. A novel molecular design. J Biol Chem. 1994 Apr 15;269(15):11208–11215. [PubMed] [Google Scholar]
  18. Magnus J. H., Stenstad T., Husby G., Kolset S. O. Isolation and partial characterization of heparan sulphate proteoglycans from human hepatic amyloid. Biochem J. 1992 Nov 15;288(Pt 1):225–231. doi: 10.1042/bj2880225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Magnus J. H., Stenstad T., Kolset S. O., Husby G. Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111. Scand J Immunol. 1991 Jul;34(1):63–69. doi: 10.1111/j.1365-3083.1991.tb01521.x. [DOI] [PubMed] [Google Scholar]
  20. Malaba L., Kindberg G. M., Norum K. R., Berg T., Blomhoff R. Receptor-mediated endocytosis of retinol-binding protein by liver parenchymal cells: interference by radioactive iodination. Biochem J. 1993 Apr 1;291(Pt 1):187–191. doi: 10.1042/bj2910187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Marinari L., Lenich C. M., Ross A. C. Production and secretion of retinol-binding protein by a human hepatoma cell line, HepG2. J Lipid Res. 1987 Aug;28(8):941–948. [PubMed] [Google Scholar]
  22. Melhus H., Båvik C. O., Rask L., Peterson P. A., Eriksson U. Epitope mapping of a monoclonal antibody that blocks the binding of retinol-binding protein to its receptor. Biochem Biophys Res Commun. 1995 May 5;210(1):105–112. doi: 10.1006/bbrc.1995.1633. [DOI] [PubMed] [Google Scholar]
  23. Monaco H. L., Rizzi M., Coda A. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science. 1995 May 19;268(5213):1039–1041. doi: 10.1126/science.7754382. [DOI] [PubMed] [Google Scholar]
  24. Murdoch A. D., Dodge G. R., Cohen I., Tuan R. S., Iozzo R. V. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem. 1992 Apr 25;267(12):8544–8557. [PubMed] [Google Scholar]
  25. Noonan D. M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., Yamada Y., Hassell J. R. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem. 1991 Dec 5;266(34):22939–22947. [PubMed] [Google Scholar]
  26. Noy N., Slosberg E., Scarlata S. Interactions of retinol with binding proteins: studies with retinol-binding protein and with transthyretin. Biochemistry. 1992 Nov 17;31(45):11118–11124. doi: 10.1021/bi00160a023. [DOI] [PubMed] [Google Scholar]
  27. Peterson P. A., Nilsson S. F., Ostberg L., Rask L., Vahlquist A. Aspects of the metabolism of retinol-binding protein and retinol. Vitam Horm. 1974;32:181–214. doi: 10.1016/s0083-6729(08)60012-6. [DOI] [PubMed] [Google Scholar]
  28. Peterson P. A. Studies on the interaction between prealbumin, retinol-binding protein, and vitamin A. J Biol Chem. 1971 Jan 10;246(1):44–49. [PubMed] [Google Scholar]
  29. Pierce A., Lyon M., Hampson I. N., Cowling G. J., Gallagher J. T. Molecular cloning of the major cell surface heparan sulfate proteoglycan from rat liver. J Biol Chem. 1992 Feb 25;267(6):3894–3900. [PubMed] [Google Scholar]
  30. ROBBINS J., RALL J. E. Proteins associated with the thyroid hormones. Physiol Rev. 1960 Jul;40:415–489. doi: 10.1152/physrev.1960.40.3.415. [DOI] [PubMed] [Google Scholar]
  31. Rescan P. Y., Loréal O., Hassell J. R., Yamada Y., Guillouzo A., Clément B. Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture. Am J Pathol. 1993 Jan;142(1):199–208. [PMC free article] [PubMed] [Google Scholar]
  32. Senoo H., Smeland S., Malaba L., Bjerknes T., Stang E., Roos N., Berg T., Norum K. R., Blomhoff R. Transfer of retinol-binding protein from HepG2 human hepatoma cells to cocultured rat stellate cells. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3616–3620. doi: 10.1073/pnas.90.8.3616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shively J. E., Conrad H. E. Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures. Biochemistry. 1976 Sep 7;15(18):3943–3950. doi: 10.1021/bi00663a006. [DOI] [PubMed] [Google Scholar]
  34. Sivaprasadarao A., Findlay J. B. Structure-function studies on human retinol-binding protein using site-directed mutagenesis. Biochem J. 1994 Jun 1;300(Pt 2):437–442. doi: 10.1042/bj3000437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sivaprasadarao A., Findlay J. B. The interaction of retinol-binding protein with its plasma-membrane receptor. Biochem J. 1988 Oct 15;255(2):561–569. [PMC free article] [PubMed] [Google Scholar]
  36. Smeland S., Bjerknes T., Malaba L., Eskild W., Norum K. R., Blomhoff R. Tissue distribution of the receptor for plasma retinol-binding protein. Biochem J. 1995 Jan 15;305(Pt 2):419–424. doi: 10.1042/bj3050419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Soprano D. R., Herbert J., Soprano K. J., Schon E. A., Goodman D. S. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem. 1985 Sep 25;260(21):11793–11798. [PubMed] [Google Scholar]
  38. Terry C. J., Damas A. M., Oliveira P., Saraiva M. J., Alves I. L., Costa P. P., Matias P. M., Sakaki Y., Blake C. C. Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J. 1993 Feb;12(2):735–741. doi: 10.1002/j.1460-2075.1993.tb05707.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Vahlquist A., Nilsson S. F., Peterson P. A. Isolation of the human retinol binding protein by affinity chromatography. Eur J Biochem. 1971 May 28;20(2):160–168. doi: 10.1111/j.1432-1033.1971.tb01374.x. [DOI] [PubMed] [Google Scholar]
  40. Vranckx R., Savu L., Maya M., Nunez E. A. Characterization of a major development-regulated serum thyroxine-binding globulin in the euthyroid mouse. Biochem J. 1990 Oct 15;271(2):373–379. doi: 10.1042/bj2710373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Westermark P., Sletten K., Johansson B., Cornwell G. G., 3rd Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2843–2845. doi: 10.1073/pnas.87.7.2843. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES